Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care Site Settings

Last updated: February 20, 2025
Sponsor: bioLytical Laboratories
Overall Status: Completed

Phase

N/A

Condition

Hepatitis

Hepatitis B

Liver Disorders

Treatment

iStatis HBsAg Test

Clinical Study ID

NCT06368479
CLS-016B
  • Ages > 18
  • All Genders

Study Summary

A prospective cross-sectional study in which surgically non-invasive sample-taking is done only for the purpose of testing the samples on iStatis HBsAg Test at the point of care.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Participants/subjects (males, females, and pregnant women) getting tested forHepatitis B virus for one or more of the following reasons:

  • at risk for Hepatitis B virus

  • having signs and symptoms indicative for Hepatitis B virus

  • Routine testing Unknown or other reasons will be captured

  • Participants/subjects of 18 years or older and, who are able to give/sign theinformed consent.

Exclusion

Exclusion Criteria:

  • Participant younger than 18 years old

  • Participants unable to provide written informed consent

Study Design

Total Participants: 1400
Treatment Group(s): 1
Primary Treatment: iStatis HBsAg Test
Phase:
Study Start date:
March 19, 2024
Estimated Completion Date:
July 19, 2024

Study Description

Participants are prospctively recruited and enrolled to participate in the study. The Capillary (fingerstick) whole blood, and venous whole blood samples (in serum separating tube (SST) and Ethylenediaminetetraacetic acid (EDTA) tube) are collected by a healthcare professional. Serum and plasma samples will be extracted through laboratory processing of the collected serum separating tube and Ethylenediaminetetraacetic acid VWB, respectively. The collected samples of capillary will be tested on iStatis HBsAg Test. The collected Ethylenediaminetetraacetic acid and serum separating tube VWB will be shipped to the central laboratory to appropriately process and extract serum and plasma samples. Ethylenediaminetetraacetic acid VWB, plasma and serum will be tested on iStatis HBsAg Test in the laboratory. An aliquot of the obtained plasma sample will be further tested for reference and confirmatory testing.

The results from iStatis HBsAg Test results will not be used for participant management decisions.

Connect with a study center

  • Epicentre Health Research

    Hillcrest, Kwazulu Natal 3650
    South Africa

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.